Introduction Lung cancer is the world's leading cause of cancer death. Low-dose computed
tomography (LDCT) screening reduced lung cancer mortality by 20% in the US National …

Background Screening with low-dose computed tomography (LDCT) reduces lung cancer
mortality; however, the most effective strategy for optimising participation is unknown. Here …

Abstract The UK Lung Cancer Screening trial (UKLS) aims to evaluate low-dose computed
tomography (LDCT) lung cancer population screening in the United Kingdom. In UKLS, a …

Background Lung cancer screening with low-dose CT reduces lung cancer mortality, but
screening requires equitable uptake from candidates at high risk of lung cancer across …

Lung cancer screening is receiving increasing attention worldwide, both in the medical
community and the general public. Multiple randomised trials—including the US National …

BACKGROUND Lung cancer kills more people than any other cancer in the UK (5-year
survival< 13%). Early diagnosis can save lives. The USA-based National Lung Cancer …

Background Previous evaluations of low-dose CT (LDCT) lung cancer screening
programmes have taken very different approaches in the design of the informative trials and …

We report baseline results of a community-based, targeted, low-dose CT (LDCT) lung
cancer screening pilot in deprived areas of Manchester. Ever smokers, aged 55–74 years …

To take lung cancer screening into national programmes, we first have to answer the
question whether low-dose computed tomography (LDCT) screening and treatment of early …

Lung cancer kills an estimated 35 000 people in the UK every year. Despite the
improvements in treating late-stage disease, lung cancer outcomes have changed little in …